Latent Multi-drug Resistant Tuberculosis: An Unaddressed Problem

@inproceedings{Gyanshankar2020LatentMR,
  title={Latent Multi-drug Resistant Tuberculosis: An Unaddressed Problem},
  author={Mishra Gyanshankar and M Nadaf Jasmin},
  year={2020}
}
It is estimated that three of every 1,000 individuals worldwide have latent Multidrug-Resistant Tuberculosis (MDR-TB) infection. Management of latent MDR-TB is an integral component in our strategies targeting global TB elimination. 

References

SHOWING 1-10 OF 14 REFERENCES
Evaluation of the Effect of Treatment of Latent Tuberculosis Infection on QuantiFERON-TB Gold Assay Results
TLDR
To evaluate the utility of the QuantiFERON-TB Gold assay for monitoring latent tuberculosis treatment efficacy, the assay was performed serially for healthcare workers receiving isoniazid therapy and cellular proliferation assays revealed persistently strong purified protein derivative responses. Expand
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
TLDR
New recommendations are made for the choice and number of drugs in a regimen, the duration of intensive and continuation phases, and the role of injectable drugs for MDR-TB. Expand
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis
  • S. Marks, S. Mase, S. Morris
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2017
TLDR
A systematic review of studies published 1 January 1994-31 December 2014 found a reduced risk of TB incidence with treatment for MDR-LTBI, suggesting effectiveness in prevention of progression to MDR -TB, and confirmed cost-effectiveness. Expand
MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network.
TLDR
The review comprehensively describes the latest information on contact tracing and LTBI management in MDR-TB contacts, while providing guidance on post-treatment functional evaluation and rehabilitation of TB sequelae, infection control and other public health priorities. Expand
Toman's Tuberculosis--Case Detection, Treatment, and Monitoring: Questions and Answers
TLDR
The second edition of this practical, authoritative reference book provides a rational basis for the diagnosis and management of tuberculosis. Expand
Undernutrition & tuberculosis in India: Situation analysis & the way forward
TLDR
Nutritional supplementation in patients with TB is associated with faster sputum conversion, higher cure and treatment completion rates, significant gain in body weight and body composition as well as better performance status. Expand
502-503
  • Link: https://bit.ly/2HptZkD 086 https://www.peertechz.com/journals/archives-of-pulmonology-and-respiratory-care Citation: Mishra G, Mulani J
  • 2020
Latent Multi-drug Resistant Tuberculosis: An Unaddressed Problem
  • Arch Pulmonol Respir Care
  • 2020
The global burden of multi-drug resistant latent Tuberculosis: recent trends and estimates using mathematical modelling
  • Lancet Infect Dis
  • 2019
Latent TB Infection : Updated and consolidated guidelines for programmatic management
  • World Health Organisation
  • 2018
...
1
2
...